1657 related articles for article (PubMed ID: 30388409)
21. RGEN Editing of RNA and DNA: The Long and Winding Road from Catalytic RNAs to CRISPR to the Clinic.
Sullenger BA
Cell; 2020 May; 181(5):955-960. PubMed ID: 32470403
[TBL] [Abstract][Full Text] [Related]
22. CRISPR/Cas9 in Genome Editing and Beyond.
Wang H; La Russa M; Qi LS
Annu Rev Biochem; 2016 Jun; 85():227-64. PubMed ID: 27145843
[TBL] [Abstract][Full Text] [Related]
23. Enhanced scale and scope of genome engineering and regulation using CRISPR/Cas in Saccharomyces cerevisiae.
Deaner M; Alper HS
FEMS Yeast Res; 2019 Nov; 19(7):. PubMed ID: 31665284
[TBL] [Abstract][Full Text] [Related]
24. CRISPR-Cas9-Mediated Genome Editing and Transcriptional Control in Yarrowia lipolytica.
Schwartz C; Wheeldon I
Methods Mol Biol; 2018; 1772():327-345. PubMed ID: 29754237
[TBL] [Abstract][Full Text] [Related]
25. Anti-CRISPR proteins targeting the CRISPR-Cas system enrich the toolkit for genetic engineering.
Liu Q; Zhang H; Huang X
FEBS J; 2020 Feb; 287(4):626-644. PubMed ID: 31730297
[TBL] [Abstract][Full Text] [Related]
26. CRISPR-Cas9 Genome Engineering: Trends in Medicine and Health.
Zaib S; Saleem MA; Khan I
Mini Rev Med Chem; 2022; 22(3):410-421. PubMed ID: 34517795
[TBL] [Abstract][Full Text] [Related]
27. CRISPR Mediated Genome Engineering and its Application in Industry.
Kaboli S; Babazada H
Curr Issues Mol Biol; 2018; 26():81-92. PubMed ID: 28879858
[TBL] [Abstract][Full Text] [Related]
28. CRISPR-Cas systems: ushering in the new genome editing era.
Perez Rojo F; Nyman RKM; Johnson AAT; Navarro MP; Ryan MH; Erskine W; Kaur P
Bioengineered; 2018; 9(1):214-221. PubMed ID: 29968520
[TBL] [Abstract][Full Text] [Related]
29. Selection and Validation of Spacer Sequences for CRISPR-Cas9 Genome Editing and Transcription Regulation in Bacteria.
Grenier F; Lucier JF; Rodrigue S
Methods Mol Biol; 2015; 1334():233-44. PubMed ID: 26404154
[TBL] [Abstract][Full Text] [Related]
30. Antiviral Goes Viral: Harnessing CRISPR/Cas9 to Combat Viruses in Humans.
Soppe JA; Lebbink RJ
Trends Microbiol; 2017 Oct; 25(10):833-850. PubMed ID: 28522157
[TBL] [Abstract][Full Text] [Related]
31. gRNA-transient expression system for simplified gRNA delivery in CRISPR/Cas9 genome editing.
Easmin F; Hassan N; Sasano Y; Ekino K; Taguchi H; Harashima S
J Biosci Bioeng; 2019 Sep; 128(3):373-378. PubMed ID: 31010727
[TBL] [Abstract][Full Text] [Related]
32. Advances in CRISPR-Cas systems for RNA targeting, tracking and editing.
Wang F; Wang L; Zou X; Duan S; Li Z; Deng Z; Luo J; Lee SY; Chen S
Biotechnol Adv; 2019; 37(5):708-729. PubMed ID: 30926472
[TBL] [Abstract][Full Text] [Related]
33. Development of CRISPR/Cas9 for Efficient Genome Editing in Toxoplasma gondii.
Shen B; Brown K; Long S; Sibley LD
Methods Mol Biol; 2017; 1498():79-103. PubMed ID: 27709570
[TBL] [Abstract][Full Text] [Related]
34. Genome-scale CRISPR pooled screens.
Sanjana NE
Anal Biochem; 2017 Sep; 532():95-99. PubMed ID: 27261176
[TBL] [Abstract][Full Text] [Related]
35. Characterization and Repurposing of Type I and Type II CRISPR-Cas Systems in Bacteria.
Hidalgo-Cantabrana C; Goh YJ; Barrangou R
J Mol Biol; 2019 Jan; 431(1):21-33. PubMed ID: 30261168
[TBL] [Abstract][Full Text] [Related]
36. Genome Editing in Penicillium chrysogenum Using Cas9 Ribonucleoprotein Particles.
Pohl C; Mózsik L; Driessen AJM; Bovenberg RAL; Nygård YI
Methods Mol Biol; 2018; 1772():213-232. PubMed ID: 29754231
[TBL] [Abstract][Full Text] [Related]
37. Design of a generic CRISPR-Cas9 approach using the same sgRNA to perform gene editing at distinct loci.
Najah S; Saulnier C; Pernodet JL; Bury-Moné S
BMC Biotechnol; 2019 Mar; 19(1):18. PubMed ID: 30894153
[TBL] [Abstract][Full Text] [Related]
38. Get ready for the CRISPR/Cas system: A beginner's guide to the engineering and design of guide RNAs.
Ma S; Lv J; Feng Z; Rong Z; Lin Y
J Gene Med; 2021 Nov; 23(11):e3377. PubMed ID: 34270141
[TBL] [Abstract][Full Text] [Related]
39. Engineering the Delivery System for CRISPR-Based Genome Editing.
Glass Z; Lee M; Li Y; Xu Q
Trends Biotechnol; 2018 Feb; 36(2):173-185. PubMed ID: 29305085
[TBL] [Abstract][Full Text] [Related]
40. Functional Features and Current Applications of the RNA-Targeting Type VI CRISPR-Cas Systems.
Perčulija V; Lin J; Zhang B; Ouyang S
Adv Sci (Weinh); 2021 Jul; 8(13):2004685. PubMed ID: 34254038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
